Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q2 2023 Earnings Call Transcript

Operator: Good afternoon. My name is Audra, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q2 2023 Vanda Pharmaceuticals Inc. Earnings Call.

Related Keywords

Delaware ,United States ,New Jersey ,Mihael Polymeropoulos ,Mihaelh Polymeropoulos ,Tim Williams ,Andrew Tsai ,Kevin Moran ,Nasdaq ,Circuit Court ,Vanda Pharmaceuticals Inc ,Vanda Pharmaceuticals ,Call Transcript July ,Chief Financial ,Vanda Pharmaceutical ,Chief Executive Officer ,Risk Factors ,Financial Condition ,General Counsel ,Orphan Drug Designation ,Antisense Oligonucleotide ,Federal Circuit ,Federal Circuit Court ,Lanham Act ,Federal Claims ,